These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32983982)

  • 1. Clinical Characteristics and Prognostic Factors of Early and Late Recurrence After Definitive Radiotherapy for Nasopharyngeal Carcinoma.
    Li F; Chen FP; Chen YP; Chen Y; He XJ; Huang XD; Zheng ZQ; Zheng WH; Liu X; Sun Y; Zhou GQ
    Front Oncol; 2020; 10():1469. PubMed ID: 32983982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
    Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
    Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different prognostic values of plasma Epstein-Barr virus DNA and maximal standardized uptake value of 18F-FDG PET/CT for nasopharyngeal carcinoma patients with recurrence.
    Shen T; Tang LQ; Luo DH; Chen QY; Li PJ; Mai DM; Guo SS; Liu LT; Qian CN; Guo X; Zeng MS; Mo HY; Mai HQ
    PLoS One; 2015; 10(4):e0122756. PubMed ID: 25853677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early versus late local recurrences after conservative treatment of breast carcinoma: differences in primary tumor characteristics and patient outcome.
    Courdi A; Largillier R; Ferrero JM; Lallement M; Raoust I; Ettore F; Peyrottes I; Chamorey E; Balu-Maestro C; Chapellier C
    Oncology; 2006; 71(5-6):361-8. PubMed ID: 17785993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to Local Recurrence as a Predictor of Survival in Patients With Soft Tissue Sarcoma of the Extremity and Abdominothoracic Wall.
    Liang Y; Guo T; Hong D; Xiao W; Zhou Z; Zhang X
    Front Oncol; 2020; 10():599097. PubMed ID: 33251152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China.
    Zhao LN; Zhou B; Shi M; Wang JH; Xiao F; Xu M; Luo SQ; Xue Y; Li JP; Tan LN
    Oral Oncol; 2012 Sep; 48(9):864-9. PubMed ID: 22445296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
    Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
    Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Epstein-Barr viral DNA complements TNM classification of nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy.
    Zhang L; Tang LQ; Chen QY; Liu H; Guo SS; Liu LT; Guo L; Mo HY; Zhao C; Guo X; Cao KJ; Qian CN; Zeng MS; Shao JY; Sun Y; Ma J; Hong MH; Mai HQ
    Oncotarget; 2016 Feb; 7(5):6221-30. PubMed ID: 26716900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome and prognostic analysis of young adults nasopharyngeal carcinoma patients of a nonendemic area in intensity-modulated radiotherapy era.
    Huang Y; Zhang J; He Q; Lan M; Feng M; Zhou J; Xu P; Li L; Yin J; Lang J
    Future Oncol; 2019 Feb; 15(4):381-389. PubMed ID: 30620231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A retrospective study comparing the outcomes and toxicities of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy for the treatment of children and adolescent nasopharyngeal carcinoma.
    Qiu WZ; Peng XS; Xia HQ; Huang PY; Guo X; Cao KJ
    J Cancer Res Clin Oncol; 2017 Aug; 143(8):1563-1572. PubMed ID: 28342002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long term outcomes and prognostic factors of n0 stage nasopharyngeal carcinoma: a single institutional experience with 610 patients.
    Sun JD; Chen CZ; Chen JZ; Li DS; Chen ZJ; Zhou MZ; Li DR
    Asian Pac J Cancer Prev; 2012; 13(5):2101-7. PubMed ID: 22901177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Mao YP; Tang LL; Chen L; Sun Y; Qi ZY; Zhou GQ; Liu LZ; Li L; Lin AH; Ma J
    Chin J Cancer; 2016 Dec; 35(1):103. PubMed ID: 28031050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.
    Liu F; Xi XP; Wang H; Han YQ; Xiao F; Hu Y; He Q; Zhang L; Xiao Q; Liu L; Luo L; Li Y; Mo Y; Ma HZ
    Radiat Oncol; 2017 Jan; 12(1):15. PubMed ID: 28587681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
    Yao JJ; Qi ZY; Liu ZG; Jiang GM; Xu XW; Chen SY; Zhu FT; Zhang WJ; Lawrence WR; Ma J; Zhou GQ; Sun Y
    Radiother Oncol; 2019 Aug; 137():137-144. PubMed ID: 31102988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.
    Xiao Y; Pan J; Chen Y; Lin S; Chen Y; Zong J; Fang Y; Guo Q; Chen B; Tang L
    Radiat Oncol; 2015 Sep; 10():204. PubMed ID: 26407897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking complements the prognostic value of baseline plasma Epstein-Barr virus deoxyribonucleic acid in patients with nasopharyngeal carcinoma undergoing intensity-modulated radiation therapy: a large-scale retrospective cohort study.
    Lv JW; Chen YP; Zhou GQ; Tang LL; Mao YP; Li WF; Guo R; Lin AH; Ma J; Sun Y
    Oncotarget; 2016 Mar; 7(13):16806-17. PubMed ID: 26919237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis.
    Luo Y; Qin Y; Lang J
    Clin Transl Oncol; 2017 Apr; 19(4):470-476. PubMed ID: 27718153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
    Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
    Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of chronic hepatitis B virus infection in patients with nasopharyngeal carcinoma: analysis of 1301 patients from an endemic area in China.
    Liu X; Li X; Jiang N; Lei Y; Tang LL; Chen L; Zhou GQ; Sun Y; Yue D; Guo R; Mao YP; Li WF; Liu LZ; Tian L; Lin AH; Ma J
    Cancer; 2014 Jan; 120(1):68-76. PubMed ID: 24114075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.